CytRx Corp. buy melinda
Start price
08.08.17
/
50%
€3.52
Target price
20.09.17
€4.33
Performance (%)
-30.90%
End price
20.09.17
€2.44
Summary
This prediction ended on 20.09.17 with a price of €2.44. Massive losses of -30.90% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| CytRx Corp. | - | - | - | - |
| iShares Core DAX® | 3.258% | 2.069% | 10.102% | 63.725% |
| iShares Nasdaq 100 | 5.697% | -0.604% | 28.972% | 87.655% |
| iShares Nikkei 225® | 7.770% | -4.746% | 52.094% | 76.545% |
| iShares S&P 500 | 2.795% | 2.251% | 23.747% | 70.231% |
Comments by melinda for this prediction
In the thread CytRx Corp. diskutieren
Gesundheit | Biotechnologie | Vereinigte Staaten
$
(Vom Mitglied beendet)